Previous Article | Next Article 
Clinical Microbiology Reviews, April 2004, p. 281-310, Vol. 17, No. 2
0893-8512/04/$08.00+0 DOI: 10.1128/CMR.17.2.281-310.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Surface Glycans of Candida albicans and Other Pathogenic Fungi: Physiological Roles, Clinical Uses, and Experimental Challenges
James Masuoka*
Department of Pathology, University of Virginia, Charlottesville, Virginia 22908-0904
Although fungi have always been with us as commensals and pathogens, fungal infections have been increasing in frequency over the past few decades. There is a growing body of literature describing the involvement of carbohydrate groups in various aspects of fungal disease. Carbohydrates comprising the cell wall or capsule, or as a component of glycoproteins, are the fungal cell surface entities most likely to be exposed to the surrounding environment. Thus, the fungus-host interaction is likely to involve carbohydrates before DNA, RNA, or even protein. The interaction between fungal and host cells is also complex, and early studies using whole cells or crude cell fractions often produced seemingly conflicting results. What was needed, and what has been developing, is the ability to identify specific glycan structures and determine how they interact with immune system components. Carbohydrate analysis is complicated by the complexity of glycan structures and by the challenges of separating and detecting carbohydrates experimentally. Advances in carbohydrate chemistry have enabled us to move from the foundation of composition analysis to more rapid characterization of specific structures. This, in turn, will lead to a greater understanding of how fungi coexist with their hosts as commensals or exist in conflict as pathogens.
* Mailing address: James Masuoka, Department of Pathology, University of Virginia Health System, P.O. Box 800904, Charlottesville, VA 22908-0904. Phone: (434) 243-2744. Fax: (434) 924-2151. E-mail:
jm2n{at}virginia.edu.
Clinical Microbiology Reviews, April 2004, p. 281-310, Vol. 17, No. 2
0893-8512/04/$08.00+0 DOI: 10.1128/CMR.17.2.281-310.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wanchoo, A., Lewis, M. W., Keyhani, N. O.
(2009). Lectin mapping reveals stage-specific display of surface carbohydrates in in vitro and haemolymph-derived cells of the entomopathogenic fungus Beauveria bassiana. Microbiology
155: 3121-3133
[Abstract]
[Full Text]
-
Freedman, M., Laks, J, Dotan, N, Altstock, R., Dukler, A, Sindic, C.
(2009). Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event. Mult Scler
15: 422-430
[Abstract]
-
Cambi, A., Netea, M. G., Mora-Montes, H. M., Gow, N. A. R., Hato, S. V., Lowman, D. W., Kullberg, B.-J., Torensma, R., Williams, D. L., Figdor, C. G.
(2008). Dendritic Cell Interaction with Candida albicans Critically Depends on N-Linked Mannan. J. Biol. Chem.
283: 20590-20599
[Abstract]
[Full Text]
-
Norice, C. T., Smith, F. J. Jr., Solis, N., Filler, S. G., Mitchell, A. P.
(2007). Requirement for Candida albicans Sun41 in Biofilm Formation and Virulence. Eukaryot Cell
6: 2046-2055
[Abstract]
[Full Text]
-
Hazen, K. C, Singleton, D. R, Masuoka, J.
(2007). Influence of outer region mannosylphosphorylation on N-glycan formation by Candida albicans: Normal acid-stable N-glycan formation requires acid-labile mannosylphosphate addition. Glycobiology
17: 1052-1060
[Abstract]
[Full Text]
-
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., Andes, D.
(2007). Putative Role of {beta}-1,3 Glucans in Candida albicans Biofilm Resistance. Antimicrob. Agents Chemother.
51: 510-520
[Abstract]
[Full Text]
-
Umeyama, T., Kaneko, A., Watanabe, H., Hirai, A., Uehara, Y., Niimi, M., Azuma, M.
(2006). Deletion of the CaBIG1 Gene Reduces {beta}-1,6-Glucan Synthesis, Filamentation, Adhesion, and Virulence in Candida albicans. Infect. Immun.
74: 2373-2381
[Abstract]
[Full Text]
-
Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., Rappuoli, R., Cassone, A.
(2005). A novel glyco-conjugate vaccine against fungal pathogens. JEM
202: 597-606
[Abstract]
[Full Text]
-
Granger, B. L., Flenniken, M. L., Davis, D. A., Mitchell, A. P., Cutler, J. E.
(2005). Yeast wall protein 1 of Candida albicans. Microbiology
151: 1631-1644
[Abstract]
[Full Text]